In contrast, down-regulation of 14-3-3 expression sensitizes cancer cells to chemotherapeutic drugs [2], [20], including prostate cancer [21], implicating the therapeutic potential of 14-3-3ζ for cancer therapy. This evidence concerns the gene YWHAQ and Familial prostate cancer.